Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-10-22
pubmed:abstractText
Our objective in this study was to identify novel metrics for efficient identification of drug targets using biological network topology data. We developed a novel paradigm and metric, namely, bridging centrality, capable of identifying nodes critically involved in connecting or bridging modular subregions of a network. The topological and biological characteristics of bridging nodes were delineated in a diverse group of published yeast networks and in three human networks: those involved in cardiac arrest, C21-steroid hormone biosynthesis, and steroid biosynthesis. The bridging centrality metric was highly selective for bridging nodes. Bridging nodes differed distinctively from nodes with high degree and betweenness centrality. Bridging nodes had lower lethality, and their gene expression was consistent with independent regulation. Analysis of biological correlates indicated that bridging nodes are promising drug targets from the standpoints of efficacy and side effects. The bridging centrality method is a promising computational systems biology tool to aid target identification in drug discovery.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1532-6535
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
563-72
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery.
pubmed:affiliation
Department of Computer Science and Engineering, State University of New York at Buffalo, Buffalo, New York, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural